Table 1.

Patient demographic characteristics

Parameter	Retrospective study	Prospective study	p value
No. of patients	26	41	N.A.
Age (years)	63.7 ± 16.4 [24, 87]^a	52.9 ± 12.2 [15, 69]^a	0.003
Gender
Female	8	18	0.315
Male	18	23	0.315
Weight (kg)	65.2 ± 12.2 [51.2, 110]^a	61.9 ± 12.6 [44, 101.4]^a	0.233
Height (cm)	166.2 ± 8.6 [150, 184]^a	163.4 ± 9.6 [146, 183]^a	0.289
BMI	23.5 ± 3.1 [17.3, 32.5]^a	23.0 ± 3.4 [16.3, 31.7]^a	0.570
Glucose level	5.38 ± 0.88 [4.3, 7.9]^a	5.34 ± 0.84 [3.8, 8.1]^a	0.846
Injected activity (MBq)	258 ± 46 [200, 407]^a	81 ± 15 [51, 115]^a	< 0.001
Injected activity/weight(MBq/kg)	3.97 ± 0.28[3.61, 4.75]^a	1.32 ± 0.18[1.10, 2.11]^a	< 0.001
Uptake time (min)	70 ± 14 [49, 97]^a	68 ± 16 [39, 105]^a	0.458
Primary cancer type			N.A.
Leukemia	1^b	3^b
Bladder cancer	1^b	0
Multiple myeloma	1^b	0
Lung cancer	6^b	9^b
Liver cancer	0	1^b
Laryngeal carcinoma	1^b	0
Bone tumor	1^b	0
Colorectal cancer	3^b	2^b
Lymphoma	5^b	8^b
Ovarian cancer	1^b	0
Breast cancer	1^b	2^b
Renal cancer	1^b	1^b
Esophageal cancer	2^b	2^b
Gastric cancer	1^b	0
Pancreatic cancer	1^b	1^b
Pelvic carcinoma	0	1^b
Tongue cancer	0	2^b
Uterine cancer	0	5^b
Aplastic anemia	0	1^b
Popliteal fossa tumor	0	1^b
Tonsil tumor	0	1^b
Nasopharyngeal cancer	0	3^b

N.A., not applicable; BMI, body mass index

^aData are presented as the mean ± standard deviation [minimum, maximum]

^bNumber of patients